Inventor · disambiguated record
Marika Nespi
Also filed as: NESPI MARIKA
23 granted patents·11 pending applications·1,103 citations·filing 2004–2024
97Inventor score
Top patents by PatentIndex Score
34 records- 0199US7893075B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2007·Granted Feb 22, 2011·96 cites·22 claims
- 0298US9260437B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Feb 16, 2016·100 cites·4 claims
- 0398US8912204B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2012·Granted Dec 16, 2014·115 cites·15 claims
- 0498US8722702B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2013·Granted May 13, 2014·60 cites·16 claims
- 0598US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0698US8404700B2Compounds modulating c-fms and/or c-kit activity and uses thereforIBRAHIM PRABHA N·Filed 2012·Granted Mar 26, 2013·63 cites·22 claims
- 0797US8461169B2Compounds modulating c-fms and/or c-kit activityZHANG JIAZHONG·Filed 2010·Granted Jun 11, 2013·59 cites·32 claims
- 0897US8158636B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 17, 2012·59 cites·16 claims
- 0997US7504509B2Compounds and methods for development of Ret modulatorsPLEXXIKON INC·Filed 2004·Granted Mar 17, 2009·153 cites·39 claims
- 1096US8067434B2Compounds and methods for development of Ret modulatorsIBRAHIM PRABHA·Filed 2008·Granted Nov 29, 2011·112 cites·10 claims
- 1195US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 1295US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 1395US7605168B2PDE4B inhibitorsPLEXXIKON INC·Filed 2005·Granted Oct 20, 2009·62 cites·16 claims
- 1493US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 1592US9873700B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jan 23, 2018·20 cites·8 claims
- 1691US10717735B2Solid forms of a compound for modulating kinasesPLEXXIKON INC·Filed 2018·Granted Jul 21, 2020·11 cites·19 claims
- 1788US10421761B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Sep 24, 2019·6 cites·11 claims
- 1888US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 1986US11103505B2Formulations of a compound modulating kinasesPLEXXIKON INC·Filed 2018·Granted Aug 31, 2021·2 cites·19 claims
- 2085US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 2184US10577366B2Crystalline forms of a compound that inhibits bromodomainPLEXXIKON INC·Filed 2018·Granted Mar 3, 2020·4 cites·16 claims
- 2284US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 2383US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 2477US11337976B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 24, 2022·1 cites·10 claims
- 2568US2019263800A1Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2018·Application pending·0 cites
- 2667US2022081436A1Solid forms of a compound for modulating kinasesPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 2767US2022184079A1Formulations of a compound modulating kinasesPLEXXIKON INC·Filed 2022·Application pending·0 cites
- 2865US2018111929A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 2963US2013303534A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 3063US2017247370A1Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2016·Application pending·0 cites
- 3163US2020299293A1Solid forms of a compound for modulating kinasesPLEXXIKON INC·Filed 2020·Application pending·0 cites
- 3260US2016176865A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 3360US2012053177A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Application pending·0 cites
- 3458US2015290205A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →